Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Molecules ; 28(2)2023 Jan 06.
Article in English | MEDLINE | ID: mdl-36677655

ABSTRACT

This study documents for the first time the phytochemical composition and biological activities of Tambourissa peltata Baker, an endemic plant from Mauritius. Phytochemical extraction was performed using ethyl acetate, methanol and distilled water as solvents. The phytochemical composition was determined through HPLC-MS and other standard assays. The DPPH, ABTS, FRAP, CUPRAC and phosphomolybdenum assays were employed for the determination of the antioxidant potential, whereas cell viability assays were used to determine the cytotoxicity. The highest phenolic and phenolic acid contents were obtained in the aqueous extract (179.91 ± 0.67 gallic acid equivalents/g and 55.74 ± 1.43 caffeic acid equivalents/g). The highest quantity of flavonoids was obtained in the ethyl acetate extract (28.97 ± 0.46 rutin equivalents/g). The methanolic extract was the highest source of flavonols (33.71 ± 0.13 mg catechin equivalents/g). A total of 34 phytochemicals were identified, mainly proanthocyanidins and flavonoid glycosides. The highest antioxidant activity in DPPH (973.40 ± 5.65 mg TE (Trolox equivalents)/g), ABTS (2030.37 ± 40.83 mg TE/g), FRAP (1461.39 ± 5.95 mg TE/g), CUPRAC (1940.99 ± 20.95 mg TE/g) and phosphomolybdenum (8.37 ± 0.23 mmol TE/g) assays was recorded for the aqueous extract. The ethyl acetate extract was the most active metal chelator. The highest acetylcholinesterase inhibitor was the methanolic extract, whereas the ethyl acetate extract was the most active against BChE. The tyrosinase enzyme was most inhibited by the methanolic extract. Alpha-amylase and glucosidase were most inhibited by the aqueous extract. The methanolic extract was capable of inducing cell cytotoxicity to the human colorectal carcinoma without damaging normal cells. T. peltata warrants further attention from the scientific community given its multifaceted biological properties.


Subject(s)
Antineoplastic Agents , Antioxidants , Plant Extracts , Humans , Acetylcholinesterase , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Antioxidants/chemistry , Flavonoids/pharmacology , Methanol/chemistry , Phytochemicals/pharmacology , Phytochemicals/chemistry , Plant Extracts/pharmacology , Plant Extracts/chemistry
2.
Antioxidants (Basel) ; 12(1)2023 Jan 12.
Article in English | MEDLINE | ID: mdl-36671049

ABSTRACT

Ravenala madagascariensis is a widely known ornamental and medicinal plant, but with a dearth of scientific investigations regarding its phytochemical and pharmacological properties. Hence, these properties were appraised in this study. The DPPH (154.08 ± 2.43 mgTE/g), FRAP (249.40 ± 3.01 mgTE/g), CUPRAC (384.57 ± 1.99 mgTE/g), metal chelating (29.68 ± 0.74 mgEDTAE/g) and phosphomolybdenum assay (2.38 ± 0.07 mmolTE/g) results demonstrated that the aqueous extract had the most prominent antioxidant activity, while the methanolic extract displayed the best antioxidant potential in the ABTS assay (438.46 ± 1.69 mgTE/g). The HPLC-ESI-Q-TOF-MS-MS analysis allowed the characterization of 41 metabolites. The methanolic extract was the most active against acetylcholinesterase. All extracts were active against the alpha-amylase and alpha-glucosidase enzymes, with the ethyl acetate extract being the most active against the alpha-amylase enzyme, while the methanolic extract showed the best alpha-glucosidase inhibition. A plethora of metabolites bonded more energetically with the assayed enzymes active sites based on the results of the in silico studies. R. madagascariensis extracts used in this study exhibited cytotoxicity against HT29 cells. The IC50 of the methanolic extract was lower (506.99 ug/mL). Based on the heat map, whereby flavonoids were found to be in greater proportion in the extracts, it can be concluded that the flavonoid portion of the extracts contributed to the most activity.

3.
Molecules ; 27(18)2022 Sep 10.
Article in English | MEDLINE | ID: mdl-36144622

ABSTRACT

Artemisia verlotiorum Lamotte is recognized medicinally given its long-standing ethnopharmacological uses in different parts of the world. Nonetheless, the pharmacological properties of the leaves of the plant have been poorly studied by the scientific community. Hence, this study aimed to decipher the phytochemicals; quantify through HPLC-ESI-MS analysis the plant's biosynthesis; and evaluate the antioxidant, anti-tyrosinase, amylase, glucosidase, cholinesterase, and cytotoxicity potential on normal (NIH 3T3) and human liver and human colon cancer (HepG2 and HT 29) cell lines of this plant species. The aqueous extract contained the highest content of phenolics and phenolic acid, methanol extracted the most flavonoid, and the most flavonol was extracted by ethyl acetate. The one-way ANOVA results demonstrated that all results obtained were statistically significant at p < 0.05. A total of 25 phytoconstituents were identified from the different extracts, with phenolic acids and flavonoids being the main metabolites. The highest antioxidant potential was recorded for the aqueous extract. The best anti-tyrosinase extract was the methanolic extract. The ethyl acetate extract of A. verlotiorum had the highest flavonol content and hence was most active against the cholinesterase enzymes. The ethyl acetate extract was the best α-glucosidase and α-amylase inhibitor. The samples of Artemisia verlotiorum Lamotte in both aqueous and methanolic extracts were found to be non-toxic after 48 h against NIH 3T3 cells. In HepG2 cells, the methanolic extract was nontoxic up to 125 µg/mL, and an IC50 value of 722.39 µg/mL was recorded. The IC50 value exhibited in methanolic extraction of A. verlotiorum was 792.91 µg/mL in HT29 cells. Methanolic extraction is capable of inducing cell cytotoxicity in human hepatocellular carcinoma without damaging normal cells. Hence, A. verlotiorum can be recommended for further evaluation of its phytochemical and medicinal properties.


Subject(s)
Antineoplastic Agents , Artemisia , Acetates , Amylases , Animals , Antioxidants/chemistry , Antioxidants/pharmacology , Cholinesterases , Flavonoids/analysis , Flavonoids/pharmacology , Flavonols , Humans , Methanol/chemistry , Mice , Monophenol Monooxygenase , Phytochemicals/analysis , Phytochemicals/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , alpha-Amylases/chemistry , alpha-Glucosidases/chemistry
4.
Food Chem Toxicol ; 156: 112432, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34293424

ABSTRACT

Herbals in the form of medicine are employed extensively around the world. Herbal and conventional medicine combination is a potentially dangerous practice mainly in comorbid, hepato insufficient and frail patients leading to perilous herb-drug interactions (HDI) and toxicity. This study features potential HDI of 15 globally famous plant species through data mining and computational methods. Several plant species were found to mimic warfarin. Phytochemicals from M. charantia induced hypoglycemica. M. chamomila and G. biloba possessed anticoagulant activities. S. hispanica reduces postprandial glycemia. R. officinalis has been reported to inhibit the efflux of anticancer substrates while A. sativum can boost the clearance of anticancer agents. P. ginseng can alter blood coagulation. A cross link of the biological and in silico data revealed that a plethora of herbal metabolites such as ursolic and rosmarinic acid among others are possible/probable inhibitors of specific CYP450 enzymes. Consequently, plant species/metabolites with a given pharmacological property/metabolizing enzyme should not be mixed with drugs having the same pharmacological property/metabolizing enzyme. Even if combined with drugs, herbal medicines must be used at low doses for a short period of time and under the supervision of a healthcare professional to avoid potential adverse and toxic effects.


Subject(s)
Computational Biology/methods , Data Mining/methods , Herb-Drug Interactions , Phytochemicals/pharmacology , Humans , Phytochemicals/pharmacokinetics
5.
Curr Neuropharmacol ; 19(9): 1416-1441, 2021.
Article in English | MEDLINE | ID: mdl-33845746

ABSTRACT

Alzheimer's disease (AD) and Parkinson's disease (PD) are notorious neurodegenerative diseases amongst the general population. Being age-associated diseases, the prevalence of AD and PD is forecasted to rapidly escalate with the progressive aging population of the world. These diseases are complex and multifactorial. Among different events, amyloid ß peptide (Aß) induced toxicity is a well-established pathway of neuronal cell death, which plays a vital function in AD. Glutamate, the major excitatory transmitter, acts as a neurotoxin when present in excess at the synapses; this latter mechanism is termed excitotoxicity. It is hypothesised that glutamate-induced excitotoxicity contributes to the pathogenesis of AD and PD. No cure for AD and PD is currently available and the currently approved drugs available to treat these diseases have limited effectiveness and pose adverse effects. Indeed, plants have been a major source for the discovery of novel pharmacologically active compounds for distinct pathological conditions. Diverse plant species employed for brain-related disorders in traditional medicine are being explored to determine the scientific rationale behind their uses. Herein, we present a comprehensive review of plants and their constituents that have shown promise in reversing the (i) amyloid-ß -related toxicity in AD models and (ii) glutamate-induced excitotoxicity in AD and PD models. This review summarizes information regarding the phytochemistry, biological and cellular activities, and clinical trials of several plant species in view to provide adequate scientific baseline information that could be used in the drug development process, thereby providing effective leads for AD and PD.


Subject(s)
Alzheimer Disease , Parkinson Disease , Plants, Medicinal , Aged , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/toxicity , Glutamic Acid/toxicity , Humans
6.
Curr Pharm Des ; 26(33): 4151-4162, 2020.
Article in English | MEDLINE | ID: mdl-32178608

ABSTRACT

Neurodegenerative disorders are estimated to become the second leading cause of death worldwide by 2040. Despite the widespread use of diverse allopathic drugs, these brain-associated disorders can only be partially addressed and long term treatment is often linked with dependency and other unwanted side effects. Nature, believed to be an arsenal of remedies for any illness, presents an interesting avenue for the development of novel neuroprotective agents. Interestingly, inhibition of cholinesterases, involved in the breakdown of acetylcholine in the synaptic cleft, has been proposed to be neuroprotective. This review therefore aims to provide additional insight via docking studies of previously studied compounds that have shown potent activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro. Indeed, the determination of potent plant-based ligands for this purpose through in silico methods enables the elimination of lengthy and costly traditional methods of drug discovery. Herein, a literature search was conducted to identify active phytochemicals which are cholinesterase inhibitors. Following which in silico docking methods were applied to obtain docking scores. Compound structures were extracted from online ZINC database and optimized using AM1 implemented in gaussian09 software. Noteworthy ligands against AChE highlighted in this study include: 19,20-dihydroervahanine A and 19, 20-dihydrotabernamine. Regarding BChE inhibition, the best ligands were found to be 8-Clavandurylkaempferol, Na-methylepipachysamine D; ebeiedinone; and dictyophlebine. Thus, ligand optimization between such phytochemicals and cholinesterases coupled with in vitro, in vivo studies and randomized clinical trials can lead to the development of novel drugs against neurodegenerative disorders.


Subject(s)
Alzheimer Disease , Neurodegenerative Diseases , Acetylcholinesterase , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Cholinesterases , Humans , Molecular Docking Simulation , Neurodegenerative Diseases/drug therapy , Phytochemicals/pharmacology , Structure-Activity Relationship
7.
J Ethnopharmacol ; 245: 112163, 2019 Dec 05.
Article in English | MEDLINE | ID: mdl-31419503

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Rodrigues, is an autonomous island that forms part of the Republic of Mauritius. It is a component of the Mascarene archipelago alongside Mauritius and Reunion island. Despite their relative geographical proximity, each island has its own unique biodiversity and indigenous knowledge. Nonetheless, there is no documentation of the use of animal-based remedies (ABR) in Rodrigues. This study was therefore designed to gather and compare primary traditional knowledge on the different ABR used by Rodriguans. AIM OF THE STUDY: To collect, analyse, document, compare, and disseminate the use of ABR against common human ailments in Rodrigues island. METHODS: Data was collected following interviews from key informants (n = 150). Primary data collected in the present study was compared with those reported from the nearest island, Mauritius. Three quantitative indices including (i) the frequency of citation, (ii) the similarity ratio and the percentage of shared uses among the two islands and (iii) new uses and percentage of new uses recorded in Rodrigues for each animal species mentioned were calculated. RESULTS: A total of 32 animal species belonging to 13 taxonomic groups among which 55% were vertebrates and 45% invertebrates were reported to treat 38 different ailment conditions. Altogether, 73 distinct medicinal preparations employing 22 different animal parts and by-products were concocted from the different animal species reported. Most used animal parts were meat (21%) followed by the whole body (14%). The preparations were either administered orally (78%) or topically (22%). Interestingly, resources such as the Rodriguan bat (Pteropus rodricensis) and honey are unique to the island and have never been studied before. Pteropus rodricensis is an endangered species while Carcharodon carcharias is a vulnerable one. The shared medicinal uses of the species among the 2 islands ranged from 0 to 50% with the most similar uses (50%) being for Columba livia and Donax Spp. respectively. The proportion of new uses of animal species recorded in Rodrigues was higher (NUR ≥ 30%) for Panulirus penicillatus, Ovis aries, Gallus gallus domesticus, Scutigera coleoptrata, Apis mellifera, Bos taurus and Capra aegagrus hircus. CONCLUSION: Rodriguans were found to possess valuable knowledge on a plethora of ABR. It is believed that the present documentation will serve to record and present this vanishing knowledge to the scientific community before it is further eroded from the island. Given the dearth of primary published information on zootherapeutic practices in Rodrigues, this study opens new avenues for biomedicine development in an attempt to develop alternative therapies or complement existing ones.


Subject(s)
Health Knowledge, Attitudes, Practice , Medicine, Traditional , Adult , Animals , Ethnopharmacology , Female , Humans , Male , Mauritius , Middle Aged , Surveys and Questionnaires , Young Adult
8.
J Relig Health ; 58(6): 2110-2143, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31115832

ABSTRACT

Mauritius is renowned for its rich floral and cultural diversity. The aim of this study was to identify and document medicinal plants exclusively employed in rituals and to promote wellness among the Hindu community. In addition, it also highlights poorly documented plants with respect to their safety, efficacy, and herb-drug interaction inducing potential. The informant group included Hindu priests (n = 14) solely, while the relative frequency of citation (RFC) and use value (UV) were utilised to analyse the data. A total of 33 plants were reported in this survey. Sixteen plants were reported by informants to have both medicinal and religious values, while the highest RFC and UV index was obtained by Ocimum tenuiflorum L. (RFC = 0.79; UV = 0.71). Nonetheless, despite known and utilised commonly for years by humanity, various plant species mentioned in this study have been poorly evaluated in randomised clinical trials and for any risks of herb-drug interactions. Hence, there are concerns surrounding the safe use of these plant species particularly among patients suffering from chronic diseases.


Subject(s)
Medicine, Traditional , Phytotherapy , Plants, Medicinal , Ceremonial Behavior , Ethnopharmacology , Health Knowledge, Attitudes, Practice , Hinduism , Humans , Mauritius , Plant Preparations , Surveys and Questionnaires
9.
Med Res Rev ; 39(6): 2153-2171, 2019 11.
Article in English | MEDLINE | ID: mdl-31006878

ABSTRACT

Antiplatelet drugs reduce the risks associated with atherothrombotic events and show various applications in diverse cardiovascular diseases including myocardial infarctions. Efficacy of the current antiplatelet medicines including aspirin, clopidogrel, prasugrel and ticagrelor, and the glycoprotein IIb/IIIa antagonists, are limited due to their increased risks of bleeding, and antiplatelet drug resistance. Hence, it is important to develop new effective antiplatelet drugs, with fewer side-effects. The vast repertoire of natural peptides can be explored towards this goal. Proteins and peptides derived from snake venoms and plants represent exciting candidates for the development of novel and potent antiplatelet agents. Consequently, this review discusses multiple peptides that have displayed antiplatelet aggregation activity in preclinical drug development stages. This review also describes the antiplatelet mechanisms of the peptides, emphasizing the signaling pathways intervened by them. Also, the hurdles encountered during the development of peptides into antiplatelet drugs have been listed. Finally, hitherto unexplored peptides with the potential to prevent platelet aggregation are explored.


Subject(s)
Peptides/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Proteins/therapeutic use , Animals , Dietary Proteins/therapeutic use , Drug Evaluation, Preclinical , Humans , Peptides/pharmacokinetics , Plants/chemistry
10.
Pharmacol Ther ; 194: 107-131, 2019 02.
Article in English | MEDLINE | ID: mdl-30268770

ABSTRACT

Flavonoids are natural polyphenolic compounds which are included in a panoply of drugs and used to treat and/or manage human ailments such as metabolic, cardiovascular, neurological disorders and cancer. Thus, the purpose of this review is to emphasize the importance of flavonoids for the treatment of autoimmune diseases and put into the limelight of the scientific community several health-promoting effects of flavonoids which could be beneficial for the development of novel drugs from natural products. Despite available reviews on flavonoids targeting various disease conditions, a comprehensive review of flavonoids for autoimmune diseases is still lacking. To the best of our knowledge, this is the first attempt to review the potential of flavonoids for autoimmune diseases. The structure-activity relationship of flavonoids in this review revealed that the rearrangement and introduction of other functional groups into the basic skeleton of flavonoids might lead to the development of new drugs which will be helpful in relieving the painful symptoms of various autoimmune diseases.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Autoimmune Diseases/drug therapy , Flavonoids/therapeutic use , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacokinetics , Anti-Inflammatory Agents/toxicity , Autoimmune Diseases/genetics , Flavonoids/chemistry , Flavonoids/pharmacokinetics , Flavonoids/toxicity , Gene Expression Regulation/drug effects , Humans , Structure-Activity Relationship
11.
Comb Chem High Throughput Screen ; 21(3): 161-174, 2018.
Article in English | MEDLINE | ID: mdl-29436996

ABSTRACT

BACKGROUND: Common auto-inflammatory disorders (CAIDs) constitute a wide array of ailments ranging from acute allergies to chronic conditions. Globally, CAIDs remain one of the leading causes of disability and morbidity. Despite playing a leading therapeutic role, the vast profusion of anti-inflammatory synthetic agents have not been able to fully resolve a panoply of CAIDs. Additionally, contemporary synthetic therapy approaches remain bounded by a wide array of limitations essentially being adverse effects and unaffordable costs. In this advent, the use of herbal products provides an interesting avenue to explore in view of developing such treatment regimens. OBJECTIVE: This review article endeavors to highlight potential herbal products and isolated phytochemicals which can be of benefit in the prophylaxis, management, and treatment alongside avoiding the relapse of CAIDs. CONCLUSION: This review article has highlighted that herbals, herbal products, and isolated metabolites hold a huge potential in the prophylaxis, management, and treatment of CAIDs. Herbals can act on various targets involved in the pathogenesis of inflammatory disorders. In addition, novel approaches for the management of CAIDs are numerous. Indeed, nanoparticles loaded with phytochemicals have been developed to specifically target the colon for IBD treatment. In silico approaches using herbals also offer unlimited avenues to decipher new pharmacophores. Investigating the potential of polyherbal formulations is another unique approach which can be investigated. Given the inefficacy of conventional medicines, the concomitant use of conventional and herbal medicines can also be explored.


Subject(s)
Autoimmune Diseases/drug therapy , Herbal Medicine/trends , Inflammation/drug therapy , Autoimmune Diseases/pathology , Humans , Phytotherapy/methods , Plants, Medicinal/chemistry
12.
Vet Res Commun ; 41(2): 147-168, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28405866

ABSTRACT

Animal rearing is the major occupation of most population of South Asian countries. Due to lack of resources and limited approach to modern medicine, most of the livestock raisers prefer to use plant-based traditional medicine also referred to as ethnoveterinary medicine (EVM). Indeed, the use of medicinal plants in South Asia dates back to several centuries with documented evidences. However, there is currently a dearth of documentation and compilation of use of medicinal plants for animal diseases in this part of the world. This review aims to provide an up-to-date compilation of common medicinal plants used for the treatment and/or management of common animal diseases in South Asian countries. Extensive literature search was conducted online and relevant data was retrieved from well-known scientific databases. A total of 276 plants belonging to 95 families have been documented to be in common use for managing 14 different categories of animal diseases. Solanaceae, Lamiaceae, Fabaceae, and Leguminosae were most common plant families in terms of their plant species used for EVM. Gastric diseases were commonly reported and accounted for 72 species of plants used for its treatment followed by the miscellaneous disorders category and skin diseases comprising of 65 and 39 plant species respectively. Herbs accounted for 46% of the total plant species, followed by trees (33%), and shrubs (18%). The EVM were applied through different routes of administration; oral administration accounted for 72% followed by topical application 27%, while burning of plant parts to create smoke around animals to repel insects was less common (1%). It is anticipated that the present review will stimulate further ethnoveterinary research among livestock disease management practices in South Asia.


Subject(s)
Medicine, Traditional/methods , Plants, Medicinal , Veterinary Medicine/methods , Animals , Asia, Western , Livestock
13.
Comb Chem High Throughput Screen ; 19(7): 554-64, 2016.
Article in English | MEDLINE | ID: mdl-27151484

ABSTRACT

Neglected tropical diseases (NTDs) flourish mostly in impoverished developing nations of the world. It is estimated that NTDs plague up to 1 billion people every year thereby inducing a massive economic and health burden worldwide. Following explosive outbreaks mostly in Asia, Latin America, Europe and the Indian Ocean, two common NTDs namely, Chikungunya and Dengue both transmitted by an infected mosquito vector principally Aedes aegypti have emerged as a major public health threat. Given the limitations of conventional medicine in specifically targeting the Chikungunya and Dengue virus (CHIKV and DENV), natural products present an interesting avenue to explore in the quest of developing novel anti; mosquito, CHIKV and DENV agents. In this endeavor, a number of plant extracts, isolated phytochemicals, essential oils and seaweeds have shown promising larvicidal and insecticidal activity against some mosquito vectors as well as anti CHIKV and DENV activity invitro. Other natural products that have depicted good potential against these diseases include; the symbiotic bacterial genus Wolbachia which can largely reduce the life span and infectivity of mosquito vectors and the marine Cyanobacterium Trichodesmium erythraeum which has shown anti- CHIKV activity at minimal cytotoxic level. The impetus of modern drug discovery approaches such as high throughput screening, drug repositioning, synthesis and computer-aided drug design will undeniably enhance the process of developing more stable lead molecules from natural products which have shown promising antiviral activity in-vitro.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Biological Products/chemistry , Chikungunya Fever/drug therapy , Dengue/drug therapy , Aedes/virology , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chikungunya Fever/epidemiology , Chikungunya Fever/etiology , Chikungunya Fever/transmission , Dengue/epidemiology , Dengue/transmission , Humans , Mosquito Control , Mosquito Vectors/virology , Neglected Diseases/drug therapy , Plant Extracts/chemistry , Plant Extracts/pharmacology
14.
J Ethnopharmacol ; 177: 61-80, 2016 Jan 11.
Article in English | MEDLINE | ID: mdl-26593215

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Despite laudable advances in conventional medicine, respiratory tract diseases (RTD) induced morbidity and mortality continue to inflict a substantial burden on healthcare systems worldwide. Similarly, in the tropical island of Mauritius, 13,320 hospital admissions and 8.2% mortality rates were attributed to RTD solely in the year 2013. Consequently, the therapeutic benefits and relief experienced with traditional medicine (TM) against RTD by the local inhabitants cannot be underestimated. The present study aims to report and quantitatively determine the extent of utilization of plant based therapies and other miscellaneous TM preparations concocted against RTD over the island. Additionally, a similarity index was generated which is indicative of the extent of harmonisation of individual plant species against RTD when the uses mentioned in the study are compared to previous ethnobotanical studies. MATERIALS AND METHODS: Data was compiled using a semi-structured questionnaire via face-to-face interviews with TM users and practitioners (n=384). Three quantitative ethnopharmacological indices (the use value (UV), informant consensus factor (ICF), and ethnobotanicity index (EI)) were calculated. We also calculated the similarity ratio, similarity percentage, new uses for each plant species and percentage of new use against RTD to compare primary data collected in the present study. RESULTS: Fifty five plants were documented to be in use against 18 RTD. The most used plant species belonged to the following taxa; Lamiaceae (9%), Fabaceae (7%) and Rutaceae (7%). Thirty two plants recorded in this study have been reported to be used against RTD in previous ethnobotanical studies, of which 22 of these plants have been attributed new uses against RTD based on the results of the present study. The remaining 23 plants species have been recorded for the first time to be used traditionally against RTD. Altogether, 81 different recipes were concocted from the medicinal plants and the most common route of administration was oral intake. Common methods of obtaining medicinal plants were from the wild, cultivation and as imported herbal products. Cough was the most common RTD managed by plant species. The largest proportion of plants were employed against cold. The preference ranking both for UV placed Curcuma longa L., Zingiber officinale Roscoe, Citrus×limonia Osbeck and Cymbopogon citratus (DC.) Stapf as the most useful plant species. Only a small proportion of the indigenous plants (7.73%) proved to be useful in TM. CONCLUSION: This study provides empirical primary ethnopharmacological data on the use of TM to manage and/or treat RTD and can contribute in preserving indigenous knowledge in Mauritius. It is anticipated that these primary data will open new avenues to identify novel drugs that can help to alleviate sufferings.


Subject(s)
Medicine, Traditional/methods , Plants, Medicinal/classification , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/therapy , Data Collection , Ethnopharmacology , Female , Humans , Male , Mauritius , Middle Aged , Phytotherapy , Surveys and Questionnaires
15.
Complement Ther Clin Pract ; 19(1): 36-43, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23337563

ABSTRACT

OBJECTIVE: To assess CAM usage among women in Mauritius. METHODS: Cross-sectional survey with a nationally-representative sample (n = 384). Quantitative indices included informant-consensus factor, use-value, fidelity-value and use-mentions were calculated. RESULTS: Thirteen therapies were identified and currently are used to treat or manage 26 ailments. These were phytotherapy (30%); yoga (13%); deep-breathing (12%); massage therapy (11%); ayurvedic medicine (8%); meditation (6%); zootherapy (6%); homeopathy (5%); exercise (3%) and reiki (3%). The most prevalent CAM was phytotherapy. Based on the quantitative ethnobotanical indices, plants commonly used were Acalphya spp., (Copper leaf), Curcuma longa (Tumeric), Cymbopogon citratus (Lemon grass), Erythroxylum hypericifolium (Bois ronde), Lens culinaris (Lentil) and Mentha piperita (Mentha). Interestingly, the present study is the first attempt to record CAM management of women's health in Mauritius. CONCLUSIONS: This study can be considered as a primary information resource recording the current use of CAM by women in Mauritius.


Subject(s)
Complementary Therapies/statistics & numerical data , Magnoliopsida , Phytotherapy/statistics & numerical data , Plants, Medicinal , Women's Health , Adult , Cross-Sectional Studies , Exercise Therapy , Female , Humans , Male , Mauritius , Middle Aged , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...